Artificial intelligence is still struggling to crack the most complex problem in pharma R&D: reliably designing new molecules that become breakthrough medicines. But drugmakers say AI is already paying off in the “unsexy” middle of development. This is where time and money are often lost to paperwork, vendor hand-offs, and slow trial start-up. At the JPMorgan Healthcare Conference in January…
Tag: Novartis
-
Malaria Breakthrough: First Treatment for Babies
In a breakthrough for global child health, Swiss authorities have approved Coartem Baby. Researchers have developed the first-ever medicine specifically designed to treat malaria in infants weighing less than five kilograms. The announcement by pharmaceutical giant Novartis marks a pivotal moment in the fight against a disease that disproportionately affects the youngest and most vulnerable. The new treatment addresses a…